SPOTS
Contact
Description
The study aims to determine whether evaluation of respiratory epithelial cell gene expression and protein profiling of exhaled breath condensate can identify ARDS subtypes. Aim 1: Perform transcriptomics on samples of nasal epithelial cells obtained from brushing in children with ARDS on days 1, 3, 7, and 14 after eligibility. Aim 2: Perform unbiased proteomic analysis on exhaled breath condensate collected from filters of subjects with ARDS who remain invasively ventilated on days 1, 3, 7, and 14 after eligibility.
Eligibility and criteria
IRB Number:
20-017205
Clinical trial phase:
N/A
Official title:
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.